Company intelligence / Profile preview

FemtoVox

Ladera Ranch, California, United Statesprweb.com ↗

Ownership: Private
Development stage: Preclinical

Overview

FemtoVox is developing a femtosecond laser surgical platform designed to deliver sub-surface tissue ablation with minimal surface damage, aiming to improve outcomes for delicate surgeries such as those involving the voice box. Early results suggest potential for higher precision and lower complication rates compared to traditional methods. The company has entered a know-how agreement with Mayo Clinic to accelerate development but has not yet reported clinical trial data or commercial launches as of mid 2025.

Therapeutic areas: PulmonologyOther
Modalities: DeviceRobotic Surgery Technology
Industry: Surgical Medical Devices

Partnerships

Mayo Clinic (know-how agreement/collaboration on technology development)

Beyond the preview

Go deeper on FemtoVox.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on FemtoVox.

Explore the full profile